diclofenac has been researched along with Kashin-Beck Disease in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Kashin-Beck Disease: Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the study was to identify adults with symptomatic Kashin-Beck disease (KBD) and observe the efficacy and safety of diclofenac sodium, naproxen, and glucosamine hydrochloride in these adult patients in Rang-tang (Sichuan Province), China." | 5.16 | Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial. ( Kang, P; Li, J; Liu, G; Liu, W; Liu, Y; Ma, X; Pei, F; Shen, B; Xie, Q; Zhou, Z, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Liu, G | 1 |
| Pei, F | 1 |
| Liu, Y | 1 |
| Zhou, Z | 1 |
| Li, J | 1 |
| Shen, B | 1 |
| Kang, P | 1 |
| Xie, Q | 1 |
| Ma, X | 1 |
1 trial available for diclofenac and Kashin-Beck Disease
| Article | Year |
|---|---|
Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; China; Diclofenac; Female; Glucosamine; Humans | 2012 |